MedPath
FDA Approval

Florexa

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 26, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Eflornithine(4170 mg in 30 g)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Florexa

Product Details

NDC Product Code
82160-125
Route of Administration
TOPICAL
Effective Date
December 26, 2023
Code: 4NH22NDW9HClass: ACTIRQuantity: 4170 mg in 30 g
© Copyright 2025. All Rights Reserved by MedPath